It correlates with size and staging, indicating a poor prognosis, whereas in adenocarcinomas, it indicates the paucity of treatment response with or without epidermal growth factor receptor (EGFR) in advanced stages [36,37,38]. Here, EGFR is linked to adenocarcinoma.